Ipamorelin

What is Ipamorelin?

Ipamorelin is a lab-made peptide that nudges your own pituitary to release a short pulse of growth hormone, and its biggest selling point is what it does not do. It is a selective agonist at the ghrelin receptor (GHS-R1a), and unlike the older peptides it replaced, it raises growth hormone without meaningfully spiking cortisol or prolactin, per Raun 1998. That clean profile is real and well-documented. The catch sits one layer down: almost none of the reasons people actually buy ipamorelin (fat loss, recovery, better sleep, anti-aging) have been tested in humans.

From the BioHarmony report, reviewed 2026-09-08.

Safety watch-outs

• New or worsening numbness or tingling (possible fluid-related nerve compression): reduce dose or stop.
• Rising fasting glucose or HbA1c: stop and consult a clinician, especially with diabetes.
• Any active or suspected cancer: do not use
• growth-hormone-axis stimulation is contraindicated.

Full risk profile in the BioHarmony report.

Dosing as published

No approved-label or study protocol is recorded for Ipamorelin yet.

Related peptides for recovery & tissue repair

1. 7.5/10BPC-157Strong recommendRecoveryNot FDA approvedBPC-157 is a 15-amino-acid gastric peptide fragment with consistent preclinical repair data, including a 2025 sports-medicine systematic review of 36 studies with 35…
2. 7.5/10TB-500 (Thymosin Beta-4 Fragment)Strong recommendRecoveryNot FDA approvedTB-500 is a synthetic LKKTETQ fragment marketed for soft-tissue repair, but most human evidence is on full-length topical thymosin beta-4: Sosne 2023 reported corneal…
3. 7.4/10GHK-Cu (Copper Peptide)Strong recommendRecoveryNot FDA approvedGHK-Cu is a human copper-binding tripeptide with the best evidence for topical skin repair and wound healing, including Mulder 1994 diabetic ulcer data showing 98.5%…
4. 7.3/10Thymosin Alpha-1Strong recommendRecoveryNot FDA approvedFDA identifies immunogenicity and peptide-impurity concerns for compounded thymosin alpha-1 and says available safety information is inadequate.